Emergence of Zaire Ebola virus disease in Guinea.

  title={Emergence of Zaire Ebola virus disease in Guinea.},
  author={Sylvain Baize and Delphine Pannetier and Lisa Oestereich and Toni Rieger and Lamine Koivogui and N'Faly Magassouba and Barr{\'e} Soropogui and Mamadou S Sow and Sakoba Ke{\"i}ta and Hilde de Clerck and Amanda Tiffany and Gemma Jim{\'e}nez Dom{\'i}nguez and Mathieu Loua and Alexis Traor{\'e} and Moussa Koli{\'e} and Emmanuel Roland Malano and Emmanuel Heleze and Anne Bocquin and St{\'e}phane M{\'e}ly and Herv{\'e} Raoul and Valérie Caro and D{\'a}niel Cadar and Martin Gabriel and Meike Pahlmann and Dennis Tappe and Jonas Schmidt-Chanasit and Benido Impouma and Abdoul Karim Diallo and Pierre B. H. Formenty and Michel van Herp and Stephan G{\"u}nther},
  journal={The New England journal of medicine},
  volume={371 15},
In March 2014, the World Health Organization was notified of an outbreak of a communicable disease characterized by fever, severe diarrhea, vomiting, and a high fatality rate in Guinea. [] Key Result Full-length genome sequencing and phylogenetic analysis showed that EBOV from Guinea forms a separate clade in relationship to the known EBOV strains from the Democratic Republic of Congo and Gabon.

Figures and Tables from this paper

Overview of Ebola virus disease in 2014
Ebola--an ongoing crisis.
The initial sequence data showed that the outbreak strain was Zaire ebolavirus, but a strain distinct from those identified in prior outbreaks, such as those in the Democratic Republic of Congo (DRC) and Gabon.
Ebola Virus Epidemiology and Evolution in Nigeria
Clinical data and contact information and genome sequences for the 2014 Nigerian Ebola virus outbreak confirm that there was a single source for the Nigerian infections, shows that the Nigerian EBOV lineage nests within a lineage previously seen in Liberia but is genetically distinct from it, and supports the conclusion that transmission from Nigeria to elsewhere did not occur.
Serological Evidence of Ebola Virus Infection in Rural Guinea before the 2014 West African Epidemic Outbreak.
A highly sensitive and specific Luminex-based assay for Ebola virus (EBOV) antibody detection was used to screen blood samples collected in the framework of the Demographic Health Survey performed in 2012 in Guinea, indicating that Zaire EBOV was circulating in rural areas of this country before the 2014 EVD outbreak.
Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis.
This review aims to provide an overview of EVD for clinicians, with the emphasis on pathogenesis, clinical manifestations, and treatment options.
Ebola Virus Disease: History, Epidemiology and Outbreaks
It is believed that contact with infected bushmeat is an important risk factor for initial spill over of the virus into the human population, and at present, there is still no registered prophylaxis or curative biologicals against EVD.
Ebola virus disease in West Africa - an unprecedented outbreak.
This editorial comments on the current outbreak of EVD in West Africa, reasons why it has proved challenging to contain, signs, symptoms and transmission, and implications for South Africa.
Ebola Viral Disease Outbreak — West Africa, 2014
Ebola disease: Infection prevention and control in hospital and community settings
The disease estimates suggest that the magnitude of the Ebola virus disease was way beyond the previous similar outbreaks and magnitude, and has grown at an exponential rate, with the number of new cases getting doubled every 20–30 days.
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
This West African variant likely diverged from central African lineages around 2004, crossed from Guinea to Sierra Leone in May 2014, and has exhibited sustained human-to-human transmission subsequently, with no evidence of additional zoonotic sources.


Ebola and marburg hemorrhagic fever.
Ebola haemorrhagic fever
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996.
This investigation suggests that human EBO-R infection is rare, and none of the 246 employees of the facilities or 4 contacts of previously antibody-positive individuals reported an Ebola-like illness.
Fruit bats as reservoirs of Ebola virus
Evidence of asymptomatic infection by Ebola virus is found in three species of fruit bat, indicating that these animals may be acting as a reservoir for this deadly virus.
Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation.
No serologic conversion was detected among contact persons in Côte d'Ivoire or Switzerland, suggesting that infection-control precautions were satisfactory, and a new subtype of Ebola was isolated from the patient's blood on days 4 and 8.
Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates.
The nonstructural secreted GP (SGP), the primary product of the GP gene, was more highly conserved than the structural GP, indicating different functional roles or evolutionary constraints for these proteins.
Ebola haemorrhagic fever in Zaire, 1976.
  • Medicine
    Bulletin of the World Health Organization
  • 1978
It was concluded that pathogenesis of the disease included non-icteric hepatitis and possibly acute pancreatitis as well as disseminated intravascular coagulation, and was caused by a virus morphologically similar to Marburg virus, but immunologically distinct.
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene.
Development and Evaluation of a Fluorogenic 5′ Nuclease Assay To Detect and Differentiate between Ebola Virus Subtypes Zaire and Sudan
This assay is unique in its ability to simultaneously detect and differentiate Ebola Zaire and Ebola Sudan and is compatible with emerging rapid nucleic acid analysis platforms and therefore may prove to be a very useful diagnostic tool for the control and management of future outbreaks.